- Home
- IOVA vs RNP Comparison
IOVA vs RNP Comparison
Compare IOVA & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- RNP
- Stock Information
- Founded
- IOVA 2007
- RNP 2003
- Country
- IOVA United States
- RNP United States
- Employees
- IOVA N/A
- RNP N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- RNP Investment Managers
- Sector
- IOVA Health Care
- RNP Finance
- Exchange
- IOVA Nasdaq
- RNP Nasdaq
- Market Cap
- IOVA 975.1M
- RNP 1.0B
- IPO Year
- IOVA N/A
- RNP N/A
- Fundamental
- Price
- IOVA $1.83
- RNP $21.13
- Analyst Decision
- IOVA Buy
- RNP
- Analyst Count
- IOVA 11
- RNP 0
- Target Price
- IOVA $10.80
- RNP N/A
- AVG Volume (30 Days)
- IOVA 14.8M
- RNP 117.6K
- Earning Date
- IOVA 11-06-2025
- RNP 01-01-0001
- Dividend Yield
- IOVA N/A
- RNP 7.94%
- EPS Growth
- IOVA N/A
- RNP N/A
- EPS
- IOVA N/A
- RNP N/A
- Revenue
- IOVA $241,525,000.00
- RNP N/A
- Revenue This Year
- IOVA $68.14
- RNP N/A
- Revenue Next Year
- IOVA $56.64
- RNP N/A
- P/E Ratio
- IOVA N/A
- RNP N/A
- Revenue Growth
- IOVA 636.99
- RNP N/A
- 52 Week Low
- IOVA $1.64
- RNP $15.52
- 52 Week High
- IOVA $12.51
- RNP $21.27
- Technical
- Relative Strength Index (RSI)
- IOVA 34.71
- RNP 36.19
- Support Level
- IOVA $1.94
- RNP $21.14
- Resistance Level
- IOVA $2.20
- RNP $21.58
- Average True Range (ATR)
- IOVA 0.14
- RNP 0.28
- MACD
- IOVA -0.04
- RNP -0.02
- Stochastic Oscillator
- IOVA 3.31
- RNP 6.36
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.